Jason Coloma, Ph.D.
“Third Rock’s focus on patients keeps me believing in the work we do every day.”
At Third Rock, Jason focuses on company creation with an emphasis on business development and value creation for our portfolio companies. He is enthusiastic about Third Rock’s emphasis on group genius to build great companies. He utilizes his professional experience in business development and R&D, which he gained during his tenure at companies including Roche/Genentech, Amgen, and Cytokinetics, to deliver innovative medicines to patients.
Jason’s greatest accomplishment is being involved in the launch of Maze Therapeutics, a company focused on translating genetic insights into new medicines, and he is excited to continue creating and building transformative biotech companies. In the office, Jason is most likely to think that reading a redline document from a potential partner is a great way to spend the afternoon.
- B.S., Biology, University of San Francisco
- M.P.H., University of California, Berkeley
- Ph.D., University of California, Berkeley
- MBA, Tuck School of Business, Dartmouth University
- West Coast